STOCK TITAN
  1. Home
  2. News
  3. ELV

Elevance Health Inc - ELV STOCK NEWS

Welcome to our dedicated news page for Elevance Health (Ticker: ELV), a resource for investors and traders seeking the latest updates and insights on Elevance Health.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Elevance Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Elevance Health's position in the market.

News
Elevance Health Reports First Quarter 2024 Results
Rhea-AI Summary
Elevance Health, Inc. (ELV) reported first quarter 2024 results with operating revenue of $42.3 billion, up 0.9% from 1Q 2023. Diluted EPS increased by 15.5% to $9.59 and adjusted diluted EPS by 12.5% to $10.64. FY 2024 EPS guidance raised to over $34.05 and adjusted EPS to over $37.20. A strategic partnership with Clayton, Dubilier & Rice was announced to advance primary care and physician enablement.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.19%
Tags
earnings
-
News
Elevance Health and Clayton, Dubilier & Rice Sign Agreement to Launch Strategic Partnership to Advance Primary Care Delivery
Rhea-AI Summary
Elevance Health and Clayton, Dubilier & Rice sign a strategic partnership agreement to enhance primary care delivery, focusing on innovation, patient experience, and health outcomes. The collaboration aims to leverage the strengths of three care provider entities to improve healthcare across the United States.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
partnership
-
News
Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2024 Results on April 18, 2024
Rhea-AI Summary
Elevance Health (NYSE: ELV) will announce its first quarter 2024 financial results on April 18, 2024, with a conference call scheduled for the same day. Investors can access the call through various means, including phone numbers and a live webcast on the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.46%
Tags
earnings
News
Elevance Health Announces Closing of Paragon Healthcare Acquisition
Rhea-AI Summary
Elevance Health (NYSE: ELV) acquires Paragon Healthcare, enhancing its capabilities in multi-site infusion services and specialty pharmacy. Paragon Healthcare, a leading provider of infusion services, operates ambulatory infusion centers, home infusion pharmacies, and specialty pharmacy services across eight states, serving over 35,000 patients. The acquisition aims to provide affordable, convenient access to specialty medications for patients with chronic illnesses, ultimately improving medication adherence, lowering costs, and supporting whole health.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.76%
Tags
acquisition
-
News
Performant Financial Corporation Announces the Appointment of Dr. Shantanu Agrawal to Its Board of Directors
Rhea-AI Summary
Performant Financial Corporation (PFMT) appoints Dr. Shantanu Agrawal, M.D. to its Board of Directors, bringing expertise in healthcare policy and payment integrity. Dr. Agrawal's background includes executive roles at Elevance Health and CMS, shaping payment integrity programs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.63%
Tags
management
-
News
Elevance Health Announces Appearance at the Cowen 44th Annual Health Care Conference
Rhea-AI Summary
Elevance Health (NYSE: ELV) management to present at Cowen 44th Annual Health Care Conference. Live webcast available for interested parties. Replay accessible for 90 days. Check Elevance Health's website for more details.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.37%
Tags
none
News
Elevance Health Announces Appearance at Barclays 26th Annual Global Healthcare Conference
Rhea-AI Summary
Elevance Health (ELV) to present at Barclays 26th Annual Global Healthcare Conference in Miami, offering a live webcast for interested parties. Replay available for 90 days. Check the company's website for more details.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.37%
Tags
none
-
News
Elevance Health Named in Top 10 of America’s Most JUST Companies by JUST Capital and CNBC
Rhea-AI Summary
Elevance Health (NYSE: ELV) has been ranked #8 on the annual JUST 100 list, recognizing its commitment to serving workers, customers, communities, the environment, and shareholders. The company has been recognized for 6 consecutive years and ranked first in two categories within the healthcare industry. Gail K. Boudreaux, President and CEO, expressed gratitude for the recognition and emphasized the company's commitment to sustainability and driving health equity.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.97%
Tags
none
-
News
Elevance Health Reports Results for Fourth Quarter and Full Year 2023; Sets Full Year 2024 Outlook
Rhea-AI Summary
Elevance Health, Inc. (NYSE: ELV) reported a strong financial performance in 4Q 2023 with operating revenue of $42.5 billion, up 7% from 4Q 2022, and FY 2023 operating revenue of $170 billion, up 9.3% from FY 2022. The GAAP diluted EPS1 was $3.63, up 1.1% from 4Q 2022, and adjusted diluted EPS2 was $5.62, up 15.2%. The projected FY 2024 GAAP diluted EPS and adjusted diluted EPS2 are expected to be greater than $34.29 and $37.10 per share, respectively. The quarterly dividend has been increased by 10.1% to $1.63 per share. Operating cash flow for 2023 was $8.1 billion, and the Company repurchased 5.8 million shares of its common stock for $2.7 billion in the same year. The Health Benefits and Carelon segments also reported positive financial results, with increases in operating revenue and operating gain for both the fourth quarter and the full year of 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.32%
Tags
earnings
News
Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January 24, 2024
Rhea-AI Summary
Elevance Health (NYSE: ELV) will release fourth quarter and full year 2023 financial results on January 24, 2024 at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 Access Code - 3972058 (Domestic) 312-470-0178 Access Code - 3972058 (International) 800-568-3942 No Access Code (Domestic Replay) 203-369-3812 No Access Code (International Replay) The replay will be available from 11:30 a.m. EDT on January 24, 2024 until the end of the day on February 23, 2024. The call will also be available through a live webcast at www.elevancehealth.com under the “Investors” link. You may also access the webcast here. A webcast replay will be available following the call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.43%
Tags
earnings
Stock ELV logo
Elevance Health Inc

NYSE:ELV

ELV Rankings

#91 Ranked by Market Cap
#3284 Ranked by Stock Gains
#1736 Ranked by Dividends

ELV Stock Data

115.72B
232.05M
0.21%
92.17%
0.9%
Direct Health and Medical Insurance Carriers
Finance and Insurance
Link
US
Indianapolis

About ELV

Elevance Health, Inc. is an American health insurance provider. Prior to June 2022, Elevance Health was named Anthem, Inc.